Numeric Investors’s Ionis Pharmaceuticals IONS Stock Holding History

Numeric Investors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$518K	Buy	10,300 +5,110	+98%	+$280K	﹤0.01%	884
2017 Q3	$263K	Sell	5,190 -2,910	-36%	-$152K	﹤0.01%	1000
2017 Q2	$412K	Buy	8,100 +1,000	+14%	+$46.6K	﹤0.01%	859
2017 Q1	$285K	Buy	+7,100	New	+$319K	﹤0.01%	910
2016 Q4	–	Sell	-11,600	Closed	-$425K	–	1102
2016 Q3	$425K	Buy	11,600 +1,300	+13%	+$40.7K	﹤0.01%	835
2016 Q2	$240K	Buy	+10,300	New	+$332K	﹤0.01%	931
2015 Q2	–	Sell	-4,100	Closed	-$261K	–	999
2015 Q1	$261K	Sell	4,100 -17,600	-81%	-$1.19M	﹤0.01%	749
2014 Q4	$1.34M	Buy	21,700 +14,300	+193%	+$706K	0.02%	406
2014 Q3	$287K	Buy	+7,400	New	+$262K	﹤0.01%	696
2014 Q2	–	Sell	-12,100	Closed	-$523K	–	838
2014 Q1	$523K	Buy	+12,100	New	+$587K	0.01%	581

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Numeric Investors's IONS Position: Q4 2017 in Review

Numeric Investors increased its Ionis Pharmaceuticals (IONS) stake by 98% in Q4 2017, buying an estimated $280K and bringing the position to 10,300 shares worth $518K. The position accounts for ﹤0.01% of the portfolio, ranked #884.

Numeric Investors first reported a position in IONS in Q1 2014 and has held it in 10 quarters since. The position peaked at $1.34M in Q4 2014. 316 funds tracked by Wall St. Rank hold IONS as of Q4 2017.

Numeric Investors held 10,300 shares of Ionis Pharmaceuticals worth $518K as of Q4 2017.
Numeric Investors bought 5,110 Ionis Pharmaceuticals shares in Q4 2017, an estimated $280K.
Ionis Pharmaceuticals made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #884 holding.
Numeric Investors first reported a position in Ionis Pharmaceuticals in Q1 2014 and has held it in 10 quarters since.
Numeric Investors's Ionis Pharmaceuticals position peaked at $1.34M in Q4 2014.
316 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.